Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot3 - STU 1 Ballot 3
World
Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot3 - STU 1 Ballot 3
World
Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
| Official URL: https://fevir.net/resources/Evidence/397479 | Version: 1.0.0-ballot3 | ||||
| Standards status: Informative | Computable Name: Evidence_for_Results_for_Add_on_Amlodipine_at_6_weeks_in_GroupAssignment_Quadpill_vs_Candesartan | ||||
| Other Identifiers: FEvIR Object Identifier: FEvIR Object Identifier#397479, OID:2.16.840.1.113883.4.642.40.44.22.67 | |||||
Copyright/Legal: https://creativecommons.org/licenses/by-nc-sa/4.0/ |
|||||
This Evidence Resource is referenced in an example for the EBMonFHIR Implementation Guide.
version: 5; Last updated: 2026-06-06 18:58:12+0000
ArtifactPublicationStatus: Active
identifier: FEvIR Object Identifier/397479, Uniform Resource Identifier (URI)/urn:oid:2.16.840.1.113883.4.642.40.44.22.67
version: 1.0.0-ballot3
name: Evidence_for_Results_for_Add_on_Amlodipine_at_6_weeks_in_GroupAssignment_Quadpill_vs_Candesartan
title: Evidence for Results for Add-on Amlodipine at 6 weeks in GroupAssignment: Quadpill vs. Candesartan
citeAs:
Evidence for Results for Add-on Amlodipine at 6 weeks in GroupAssignment: Quadpill vs. Candesartan [Database Entry: FHIR Evidence Resource]. Contributors: Brian S. Alper, MD, MSPH [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 397479. Revised 2026-06-06. Available at: https://fevir.net/resources/Evidence/397479. Computable resource at: https://fevir.net/resources/Evidence/397479#json.
status: Active
date: 2026-11-05 14:34:28+0000
author: Brian S. Alper, MD, MSPH:
publisher: HL7 International / Clinical Decision Support
contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss
copyright:
https://creativecommons.org/licenses/by-nc-sa/4.0/
| Type | Target[x] |
| Part Of | Outcome Measure Report for QUARTET USA Trial |
description:
This Evidence Resource is referenced in an example for the EBMonFHIR Implementation Guide.
variableDefinition
variableRole: Population
observed: the study group
variableDefinition
variableRole: Exposure
variableDefinition
variableRole: Outcome
observed: Add-on Amlodipine at 6 weeks
statistic
statisticType: odds ratio
quantity: 0.08
numberAffected: 22
SampleSizes
Extension NumberOfParticipants KnownDataCount 62 62 attributeEstimate
type: confidence interval
level: 0.95
range: 0.02-0.41
attributeEstimate
type: p-value
quantity: 0.003
IG © 2024+ HL7 International / Clinical Decision Support.
Package hl7.fhir.uv.ebm#1.0.0-ballot3 based on FHIR 6.0.0-snapshot1.
Generated
2026-11-05
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change